Prestige Consumer Healthcare
About: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Employees: 600
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
117% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 23
100% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 4 (+2) [Q1 2025]
7% more capital invested
Capital invested by funds: $4.1B [Q4 2024] → $4.39B (+$299M) [Q1 2025]
6% more funds holding
Funds holding: 333 [Q4 2024] → 354 (+21) [Q1 2025]
2.94% less ownership
Funds ownership: 106.18% [Q4 2024] → 103.24% (-2.94%) [Q1 2025]
32% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 152
79% less call options, than puts
Call options by funds: $9K | Put options by funds: $43K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
RBC Capital | 15%upside $97 | Sector Perform Maintained | 21 Mar 2025 |
Financial journalist opinion
Based on 10 articles about PBH published over the past 30 days
